IMPEL PHARMACEUTICALS INC: cashflow_investing

Value{"amount": -8000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2022-01-01 – 2022-03-31
Statuscurrent
EntityIMPEL PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-22-009951 · Open the official SEC filing →
Retrieved: 2026-08-19T14:16:31.466222+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001445499/cashflow-investing/2022-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/4e1b480f-8152-495e-8372-d487a55d8404

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies